BRAINSTORM CELL THERAPEUTICS INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BCLI

organization

SIC: 2836

Also known as: Brainstorm Cell Therapeutics Inc.

SEC Insider

$13.98B

418 transactions

Summary

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.1MSales: $2.1M41 insiders

Date	Insider	Type	Value
2026-02-26	Dagher Ibrahim B.	A	$158K
2026-02-26	HARTOUNIAN HARTOUN	A	$158K
2026-02-26	Naor Nir	A	$126K
2026-02-26	Lindborg Stacy	A	$105K
2026-02-26	Polverino Anthony J.	A	$105K
2026-02-26	Bairu Menghisteab	A	$105K
2026-02-26	ARBEL IRIT	A	$0
2026-02-26	FRENKEL JACOB A	A	$0
2026-02-26	Patlis Alla(See Remarks)	A	$0
2026-02-26	Yablonka Uri(EVP & Chief Business Officer)	A	$0
2026-02-26	Lebovits Chaim(President & CEO)	A	$0
2025-01-01	ARBEL IRIT	A	$0
2025-01-01	Bairu Menghisteab	A	$0
2025-01-01	HARTOUNIAN HARTOUN(EVP, Chief Operating Officer)	A	$0
2025-01-01	Lindborg Stacy	A	$0
2025-01-01	Naor Nir	A	$0
2025-01-01	Patlis Alla(See Remarks)	A	$0
2025-01-01	Yablonka Uri(EVP & Chief Business Officer)	A	$0
2025-01-01	Yablonka Uri(EVP & Chief Business Officer)	A	$0
2025-01-01	Polverino Anthony J.	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

BRAINSTORM CELL THERAPEUTICS INC. — Contributions, Lobbying & Contracts | Poliscope